Events and Presentations
Upcoming Events
Apr 7 - Apr 10, 2019 Pad Chivukula, CSO and COO, will be a scientific organizer at the 2019 Keystone Symposia on Protein Replacement
Apr 2, 2019 Joseph Payne, President and CEO, will present at JLABS
Mar 18, 2019 at 11:00 AM PDT Joseph Payne, President & CEO, will present at the 31st Annual ROTH Conference
Feb 27, 2019 at 11:30 AM EST Joseph Payne, President & CEO, will present at the Leerink 8th Annual Global Healthcare Conference
Feb 11, 2019 at 9:15 AM EST Joseph Payne, President & CEO, will present at BIO CEO & Investor Conference
Jan 6, 2019 at 11:30 AM PST Joe Payne, President & CEO of Arcturus Therapeutics, will be Presenting at the East/West CEO Conference, in a Panel Discussion called “Early Stage Biotech Panel: Strategies for Survival”
Jan 5, 2019 at 12:30 PM PST Joe Payne, President & CEO of Arcturus Therapeutics, will be Moderating the Fireside Chat at the East/West CEO Conference, with the Head of J&J innovation California, Rowan Chapman, Titled “Innovation and Strategic Growth Strategies for Biopharma"
Dec 11, 2018 at 2:00 PM EST Pad Chivukula, CSO and COO, will provide a brief over view of company technology. Key Opinion Leader Annette Feigenbaum, MBChB, FRCP, DABMG (UC San Diego) discusses Ornithine transcarbamylase (OTC) deficiency.
The call will feature a presentation by key opinion leader Annette Feigenbaum, MBChB, FRCP, DABMG (UC San Diego), who will discuss the disease pathogenesis, manifestation, natural history and current treatment options for Ornithine transcarbamylase (OTC) deficiency. Dr. Feigenbaum will be available to answer questions at the conclusion of the call.
Dr. Pad Chivukula, Chief Scientific Officer of Arcturus Therapeutics, will also provide a brief overview of the company's LUNAR-OTC program, which utilizes the company's proprietary LUNAR® delivery platform to safely and effectively deliver OTC mRNA to liver cells, resulting in restoration of disease markers to normal levels.
Nov 13, 2018 from 10:45 AM to 12:35 PM EST Pad Chivukula, CSO and COO, to present at the mRNA Health Conference on LUNAR: Enabling Delivery of mRNA Therapeutics and Vaccines
Oct 18, 2018 from 11:15 AM to 1:15 PM MDT North American Cystic Fibrosis Conference (NACFC)
Location
Denver, Colorado
Past Events
Apr 7 - Apr 10, 2019 Pad Chivukula, CSO and COO, will be a scientific organizer at the 2019 Keystone Symposia on Protein Replacement
Apr 2, 2019 Joseph Payne, President and CEO, will present at JLABS
Mar 18, 2019 at 11:00 AM PDT Joseph Payne, President & CEO, will present at the 31st Annual ROTH Conference
Feb 27, 2019 at 11:30 AM EST Joseph Payne, President & CEO, will present at the Leerink 8th Annual Global Healthcare Conference
Feb 11, 2019 at 9:15 AM EST Joseph Payne, President & CEO, will present at BIO CEO & Investor Conference
Jan 6, 2019 at 11:30 AM PST Joe Payne, President & CEO of Arcturus Therapeutics, will be Presenting at the East/West CEO Conference, in a Panel Discussion called “Early Stage Biotech Panel: Strategies for Survival”
Jan 5, 2019 at 12:30 PM PST Joe Payne, President & CEO of Arcturus Therapeutics, will be Moderating the Fireside Chat at the East/West CEO Conference, with the Head of J&J innovation California, Rowan Chapman, Titled “Innovation and Strategic Growth Strategies for Biopharma"
Dec 11, 2018 at 2:00 PM EST Pad Chivukula, CSO and COO, will provide a brief over view of company technology. Key Opinion Leader Annette Feigenbaum, MBChB, FRCP, DABMG (UC San Diego) discusses Ornithine transcarbamylase (OTC) deficiency.
The call will feature a presentation by key opinion leader Annette Feigenbaum, MBChB, FRCP, DABMG (UC San Diego), who will discuss the disease pathogenesis, manifestation, natural history and current treatment options for Ornithine transcarbamylase (OTC) deficiency. Dr. Feigenbaum will be available to answer questions at the conclusion of the call.
Dr. Pad Chivukula, Chief Scientific Officer of Arcturus Therapeutics, will also provide a brief overview of the company's LUNAR-OTC program, which utilizes the company's proprietary LUNAR® delivery platform to safely and effectively deliver OTC mRNA to liver cells, resulting in restoration of disease markers to normal levels.
Nov 13, 2018 from 10:45 AM to 12:35 PM EST Pad Chivukula, CSO and COO, to present at the mRNA Health Conference on LUNAR: Enabling Delivery of mRNA Therapeutics and Vaccines
Oct 18, 2018 from 11:15 AM to 1:15 PM MDT North American Cystic Fibrosis Conference (NACFC)
Location
Denver, Colorado